What is Gyre Therapeutics, Inc.'s total revenue?

Gyre Therapeutics, Inc. (GYRE) reported total revenue of $22.52M in Q1 2026.

How has Gyre Therapeutics, Inc.'s total revenue changed year-over-year?

Gyre Therapeutics, Inc.'s total revenue increased by 2.1% year-over-year, from $22.06M to $22.52M.

What is the long-term trend for Gyre Therapeutics, Inc.'s total revenue?

Over 3 years (2021 to 2025), Gyre Therapeutics, Inc.'s total revenue has grown at a 151.4% compound annual growth rate (CAGR), from $7.34M to $116.59M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Gyre Therapeutics, Inc. GYRE Total Revenue

Total Revenue at other companies

Eli LillyLLY

$19.8B+55.5%

Madrigal Pharmaceuticals, Inc.MDGL

$311.34M+127%

Viking TherapeuticsVKTX

$0—

Theravance BiopharmaTBPH

$17.7M+15.0%

Rigel PharmaceuticalsRIGL

$58.82M+10.3%

Zevra Therapeutics, Inc.ZVRA

$36.22M+77.5%

Segments

By segment

See full

Gyre Pharmaceuticals$22.52M+2.1%

All Other Segments$0—

Gyre$0—

By product

See full

Contiva$849+204%

Etorel$672—

Other Product$31-57.5%

Other financials

Income statement

See full

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s total revenue?: Gyre Therapeutics, Inc. (GYRE) reported total revenue of $22.52M in Q1 2026.
How has Gyre Therapeutics, Inc.'s total revenue changed year-over-year?: Gyre Therapeutics, Inc.'s total revenue increased by 2.1% year-over-year, from $22.06M to $22.52M.
What is the long-term trend for Gyre Therapeutics, Inc.'s total revenue?: Over 3 years (2021 to 2025), Gyre Therapeutics, Inc.'s total revenue has grown at a 151.4% compound annual growth rate (CAGR), from $7.34M to $116.59M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.